Authors
Loading...
This review highlights strategies targeting senescence to improve outcomes in regenerative medicine and oncology, suggesting new therapeutic approaches that involve senolytics and monoclonal antibody.
Steven Januar Kusmanto (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: